Key facts
| Price (PPV) | 51.80 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | enalapril |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09BA02 |
| Manufacturer | AFRIC-PHAR |
| Presentation | Boîte de 28 |
| Nature | Médicament |
| Hospital price | 32.40 MAD |
| Data collected on | 9/8/2026 |
Indications
Tous les degrés de gravité de l’hypertension artérielle essentielle; hypertension rénovasculaire; traitement de l’insuffisance cardiaque symptomatique; traitement de la dysfonction ventriculaire gauche asymptomatique avec une fraction d’éjection inférieure à 35%, et de ce fait, prévention de l’insuffisance cardiaque symptomatique.
Find an open pharmacy
On-call pharmacies near you
About Prilvas 5 mg
Prilvas 5 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by AFRIC-PHAR and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Prilvas 5 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Prilvas 5 mg
Answers to common questions from Moroccan patients about this drug.